Patient Guide: Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 49 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05925530
Status: ACTIVE_NOT_RECRUITING
Condition: Non-small Cell Lung Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 49 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • The Bronx, New York
  • Houston, Texas
  • Charlottesville, Virginia
  • • And 46 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily